|
Merck's New Cervical Cancer Vaccine, GARDASIL(R), Unanimously Recommended by CDC Advisory Panel and Pfizer Plans Generic Zoloft Response.
Publication: M2 Presswire Publication Date: 30-JUN-06 |
|
|
|
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
|
|
|
COPYRIGHT 2006 M2 Communications Ltd.
M2 PRESSWIRE-30 June 2006-U.S. Equity News: Merck's New Cervical Cancer Vaccine, GARDASIL(R), Unanimously Recommended by CDC Advisory Panel and Pfizer Plans Generic Zoloft Response(C)1994-2006 M2 COMMUNICATIONS LTD
RDATE:30062006
City of Industry, CA - Pharmaceuticals Instruments industry alert provided by U.S. Equity News. Merck & Co., Inc. (NYSE:MRK) announced recently that the U.S. Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) voted unanimously to recommend that girls and women 11 to 26...
Read the full article for free courtesy of your local library.
|
|
|
|
 |
| More Articles from M2 Presswire |
New EMEA partner programme from Network General promises net benefits;...
June 30, 2006
|
StockGuru Price and Volume Alerts for Friday June 30, 2006 - One Compa...
June 30, 2006
|
StockGuru Price and Volume Alerts for Friday June 30, 2006 - One Compa...
June 30, 2006
|
New Crop-Yield Study Casts Doubt on a Climate-Change Prediction.
June 30, 2006
|
StockGuru Price and Volume Alerts for Friday June 30, 2006 - One Compa...
June 30, 2006
|
|
| Find companies classified under Pharmaceutical preparations |
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
